FAVA, MARCO

FAVA, MARCO  

Universita' degli Studi di MILANO  

Mostra records
Risultati 1 - 5 di 5 (tempo di esecuzione: 0.0 secondi).
Titolo Data di pubblicazione Autori Tipo File Abstract
Clinical characteristics and outcomes of vaccinated patients hospitalised with SARS-CoV-2 breakthrough infection: Multi-IPV, a multicentre study in Northern Italy 2024 Villa, SimoneScaglione, GiovanniBai, FrancescaVarisco, BenedettaBono, ValeriaViero, GiuliaMantero, MarcoPeyvandi, FloraGori, AndreaBandera, AlessandraBosari, SilvanoDell’Orto, SilviaValenti, LucaGori. , AndreaBandera, AlessandraMangioni, DavideBozzi, GiorgioUngaro, RiccardoAncona, GiuseppeBolis, MatteoIannotti, NathalieCastelli, ValeriaPalomba, EmanueleFava, MarcoPeri, Carlo AlbertoViero, GiuliaPastore, ValeriaLiparoti, AriannaMuheberimana, ToussaintGiommi, AlessandroBobbio, ChiaraPeyvandi, FloraGualtierotti, RobertaRossio, RaffaellaPagliaro, EricaDe Caro, MicheleGiachi, AndreaMontano, NicolaVigone, BarbaraBellocchi, ChiaraCarandina, AngelicaTobaldini, EleonoraBlasi, FrancescoAliberti, StefanoTerranova, LeonardoMisuraca, SofiaD’Adda, AliceDi Pasquale, MartaMantero. , MarcoContarini, MartinaMorlacchi, LetiziaGramegna, AndreaPappalettera, MariaCavallini, MirtaBuscemi, AgataVicenzi, MarcoCostantino, GiorgioSolbiati, MonicaFurlan, LudovicoMancarella, MartaFanin, AlicePassarella, MarieleBilli, FilippoAccordino, SilviaMaira, DilettaMotta, IreneScaramellini, NataliaFracanzani, Anna LudovicaLombardi, RosaCespiati, AnnalisaCesari, MatteoProietti, MarcoCalcaterra, LauraMandelli, ClaraCerizza, ArturoGrasselli, GiacomoSartori, FilippoBonfanti, PaoloHarari, SergioElia, DavideRossi, IlariaIannuzzi, PasqualinaLeone, Sara + Article (author) -
Mucormycosis in CAPA, a possible fungal super-infection 2021 Paola SaltiniEmanuele PalombaValeria CastelliMarco FavaMarco ManteroFrancesco BlasiAlessandra BanderaAndrea GoriAndrea Lombardi + Article (author) -
Preliminary Evidence of Good Safety Profile and Outcomes of Early Treatment with Tixagevimab/Cilgavimab Compared to Previously Employed Monoclonal Antibodies for COVID-19 in Immunocompromised Patients 2023 Andrea LombardiGiulia VieroSimone VillaEmanuele PalombaNathalie IannottiCamilla GenoveseMara TomaselloAnna TonizzoMarco FavaLetizia Corinna MorlacchiGiuseppe CastellanoRamona CassinMaria CarrabbaAndrea GoriAlessandra Bandera + Article (author) -
Preliminary Evidence of Good Safety Profile and Outcomes of Early Treatment With Tixagevimab/Cilgavimab Compared to Previously Employed Monoclonal Antibodies for COVID-19 in Immunocompromised Patients 2023 Andrea LombardiGiulia VieroSimone VillaEmanuele PalombaCecilia Azzara'Nathalie IannottiCamilla GenoveseMara TomaselloAnna TonizzoMarco FavaLetizia MorlacchiGiuseppe CastellanoRamona CassinMaria CarrabbaAndrea GoriAlessandra Bandera + Article (author) -
Safety Profile and Outcomes of Early COVID-19 Treatments in Immunocompromised Patients: A Single-Centre Cohort Study 2022 Simone VillaCamilla GenoveseMara TomaselloAnna TonizzoMarco FavaNathalie IannottiMatteo BolisLetizia Corinna MorlacchiGiuseppe CastellanoRamona CassinMaria CarrabbaANDREA GORIAlessandra BanderaAndrea Lombardi + Article (author) -